And then there is the potential for side effects
Candidates most likely to benefit from GLP-1's anti-inflammatory effects include those with metabolic syndrome, elevated inflammatory markers, insulin resistance, or type 2 diabetes
Medicare explicitly excludes weight medications, Kahan, who consults with Novo Nordisk, says
Mild Irritation: Often occurs in the first few applications and subsides as the skin acclimates
September 4, 2024: Science Day held in the Ozempic lawsuit
Using degraded medication may result in: Suboptimal blood glucose control in patients with type 2 diabetes Reduced weight loss efficacy for those using GLP-1 agonists for weight management Unpredictable dosing , as degradation may be partial rather than complete Patients with diabetes who suspect reduced medication efficacy should monitor their blood glucose more frequently and contact their GP or diabetes care team if they have concerns about medication storage or if their diabetes control deteriorates unexpectedly